J M Vernejoux
Overview
Explore the profile of J M Vernejoux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Izadifar A, Vernejoux J, Raherison C, Sayago I, Merville J, Deminiere D, et al.
Rev Mal Respir
. 2007 Jun;
19(1):100-2.
PMID: 17546822
Renal complications of sarcoidosis are rare but they may lead to renal failure. The two most common mechanisms are interstitial nephritis and acute hypercalcaemic renal failure. We report the case...
2.
Begueret H, Berger P, Vernejoux J, Dubuisson L, Marthan R, Tunon-de-Lara J
Thorax
. 2006 Dec;
62(1):8-15.
PMID: 17189531
Background: Recent observations in asthma suggest that bronchial smooth muscle is infiltrated by inflammatory cells including mast cells. Such an infiltration may contribute to airway remodelling that is partly due...
3.
Nguyen L, Raherison C, Lheureux M, Nocent-Ejnaini C, Vernejoux J, Tunon-de-Lara J, et al.
Rev Mal Respir
. 2005 Aug;
22(2 Pt 1):227-38.
PMID: 16092161
Introduction: The level of a patient's knowledge about his disease and its treatment is an essential part of an educational assessment. It is useful therefore to make use of a...
4.
Lheureux M, Raherison C, Vernejoux J, Nguyen L, Nocent C, Tunon de Lara M, et al.
Lung Cancer
. 2004 Jan;
43(2):175-82.
PMID: 14739038
Background: Quality of life (QOL) is an important component of evaluation in oncology. Usually, QOL is used in phase III studies to compare two treatments. The aim of this trial...
5.
Begueret H, Vergier B, Begueret J, Vernejoux J, Jougon J, Trouette R, et al.
Eur J Cancer
. 2002 Nov;
38(17):2325-30.
PMID: 12441270
High grade lung neuroendocrine carcinomas, like small and large cell neuroendocrine carcinomas, pose therapeutic problems. Most initially respond to chemotherapeutic agents, but early relapses are frequent and are resistant to...
6.
Nguyen L, Raherison C, Vernejoux J, Tunon-de-Lara J, Taytard A
Rev Mal Respir
. 2002 Aug;
19(3):301-9.
PMID: 12161696
The impact of asthma on every day life is an important consideration in asthma management. Tobacco use often starts during adolescence, but little is known about its effect on the...
7.
Perol M, Lena H, Thomas P, Robinet G, Fournel P, Coste E, et al.
Ann Oncol
. 2002 Jun;
13(5):742-7.
PMID: 12075743
Background: The potential absence of cross-resistance between cisplatin and docetaxel in non-small-cell lung cancer (NSCLC) suggests that alternating regimens of cisplatin-based chemotherapy and docetaxel might increase the activity of chemotherapy...
8.
Thomas P, Robinet G, Ferri-Dessens R, Lena H, Gouva S, Vernejoux J, et al.
Lung Cancer
. 2002 Apr;
36(2):191-8.
PMID: 11955654
Background: The purpose of this study was to determine the maximum-tolerated dose (MTD) and the dose-limiting toxicity (DLT) of the 21 days carboplatin plus gemcitabine regimen in previously untreated patients...
9.
Vernejoux J, Raherison C, Combe P, Villanueva P, Laurent F, Tunon de Lara J, et al.
Respir Med
. 2001 Nov;
95(11):857-62.
PMID: 11716198
We prospectively considered 65 patients admitted for a spontaneous pneumothorax (SP) to describe the pragmatic management of SP, the first recurrence-free interval after medical therapeutic procedure and to specify the...
10.
Raherison C, Tunon-de-Lara J, Vernejoux J, Taytard A
Respir Med
. 2000 Dec;
94(11):1047-52.
PMID: 11127490
The objective of this study was to describe asthma exacerbation self-management in children and adolescents. We used a cross-sectional study population enrolled in the International Study of Asthma and Allergies...